Zenith Drugs P/B Ratio
Current P/B Ratio
1.23
Moderate Valuation
Moderate - Reasonably valued relative to book value
Zenith Drugs P/B ratio. Zenith Drugs (ZENITHDRUG) P/B ratio is 1.23 (Moderate), book value per share ₹36.47 vs Healthcare average P/B of 0.01 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see Zenith Drugs share price chart.
Current Valuation Metrics
P/B Ratio
1.23
Current Price
₹
Book Value/Share
₹36.47
Exchange
None
Book Value Breakdown (2024)
Balance Sheet Components
Total Equity
₹62 Cr
Share Capital
₹17 Cr
Reserves & Surplus
₹45 Cr
Outstanding Shares
17,000,000
Book Value per Share
₹36.47
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
0.01
Sector Median
0.61
Sector Rank
#11 of 50
Sector Percentile
22.0%
ZENITHDRUG P/B Ratio — Valuation Insights & Book Value Analysis
Zenith Drugs price-to-book ratio interpretation, valuation status and historical context — current P/B 1.23 (Moderate). View ZENITHDRUG price range for the annual high/low range and current price position.
- Trading at premium to sector average PB of 0.01
ZENITHDRUG vs Healthcare Peers — P/B Ratio Comparison
Zenith Drugs P/B 1.23 vs Healthcare average 0.01, median 0.61 — range -6.55–1.07.
Sector Average
0.01
Sector Median
0.61
Lowest P/B
-6.55
Highest P/B
1.07
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.19 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |